Goldman Sachs downgraded Thoratec (NASDAQ: THOR) from Buy to Neutral with a price target of $37.00 (from $42.00). Analyst David ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE